Abcodia Abcodia's ROCA Ovarian Cancer Test Could Be Useful in High-Risk Patients, Studies Suggest Premium A pair of studies indicate the test could aid monitoring of high-risk patients, though concerns voiced by the FDA and others are still to be fully addressed. U of Manchester to Run Abcodia Lung Cancer Collaboration From New $27M Biomarker Discovery Center Premium Opening next year with funds from the UK's Medical Research Council, the center will have roughly 12 new mass specs for discovery and targeted proteomics. Abcodia to Launch ROCA Ovarian Cancer Test in UK and US This Year Premium In the UK it initially will be offered through private clinics on a "self-pay" basis, while in the US it will be sold as a laboratory-developed test through Abcodia's CLIA lab. Abcodia Raises $8M to Support Launch of Ovarian Cancer Screening Test The company plans to launch the test, which uses serial CA-125 measurements, in the UK this summer and in the US later this year. Abcodia Taps Caprion's Mass Spec Proteomics Platforms for Cancer Biomarker Development Premium Caprion will use its discovery and targeted mass spec platforms to analyze roughly 400 samples from the UK Collaborative Trial for Ovarian Cancer Screening. Dec 10, 2014 Additional Members Join UK Cancer Consortium Sep 15, 2014 OncoCyte, Abcodia Collaborate on Breast Cancer Dx Sep 20, 2013 In Brief This Week: Life Technologies; PerkinElmer; Agilent; Activiomics, KHK; Cancer Genetics, Roche Servicios; More Aug 30, 2013 4,000-plus Patient Study Suggests ROCA Test Specific Enough for Use as Ovarian Cancer Screening Dx Premium Jun 12, 2013 Abcodia, AIT Collaborate to Validate Cancer Biomarkers Jun 6, 2013 CRUK's Commercial Branch, Abcodia Launch Cancer Biomarker Collaboration Sep 21, 2012 People in the News: Additions to Abcodia Premium Feb 28, 2012 Oslo University Hospital Licenses Colorectal Cancer Markers to OGT for Test Development Premium Feb 17, 2012 Abcodia, VolitionRx Collaborate on Nucleosome-based Dx for Cancer Nov 8, 2011 OGT to Use Protein, MiRNA Platforms in Biomarker-Discovery Pact with Abcodia Premium Nov 7, 2011 Abcodia, OGT Partner on Cancer Biomarker Discovery May 24, 2011 UK Startup Abcodia Raises $1.4M Mar 31, 2011 Startup Abcodia Banking on Preclinical Samples for Better Tests Mar 25, 2011 Movers & Shakers: Mar 25, 2011 Premium Breaking News BostonGene, Johns Hopkins University Partner for Multiple Cancer Clinical Research Projects KromaTid, Noble Life Sciences Ink Distribution, OEM Agreement Promega to Develop Microsatellite Instability Companion Diagnostic Kit With GlaxoSmithKline ZeptoMetrix Quality Control Products Receive IVDR Certification Verily Awarded CDC Contract for Wastewater Surveillance The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.